EMDB/PDB/SASBDBから引用されている文献のデータベース

キーワード
構造解析手法	All X線回折 NMR 電子顕微鏡小角散乱中性子線回折線維回折粉末回折赤外分光 EPR FRET 理論モデルハイブリッド
著者・登録者
ジャーナル
IF	>30 >20 >10 >5 all

タイトル	Design, Synthesis, X-ray Crystallography, and Biological Activities of Covalent, Non-Peptidic Inhibitors of SARS-CoV-2 Main Protease.
ジャーナル・号・ページ	Acs Infect Dis., Vol. 10, Page 715-731, Year 2024
掲載日	2023年8月4日 (構造データの登録日)
著者	Ashraf-Uz-Zaman, M. / Chua, T.K. / Li, X. / Yao, Y. / Moku, B.K. / Mishra, C.B. / Avadhanula, V. / Piedra, P.A. / Song, Y.
リンク	Acs Infect Dis. / PubMed:38192109
手法	X線回折
解像度	1.52 - 1.98 Å
構造データ	PDB-8tpb: Synthesis, X-Ray Crystallographic and Biological Activities of Covalent, Non-Peptidic Inhibitors of SARS-CoV-2 Main Protease 手法: X-RAY DIFFRACTION / 解像度: 1.88 Å PDB-8tpc: Synthesis, X-Ray Crystallographic and Biological Activities of Covalent, Non-Peptidic Inhibitors of SARS-CoV-2 Main Protease 手法: X-RAY DIFFRACTION / 解像度: 1.73 Å PDB-8tpd: Synthesis, X-Ray Crystallographic and Biological Activities of Covalent, Non-Peptidic Inhibitors of SARS-CoV-2 Main Protease 手法: X-RAY DIFFRACTION / 解像度: 1.68 Å PDB-8tpe: Synthesis, X-Ray Crystallographic and Biological Activities of Covalent, Non-Peptidic Inhibitors of SARS-CoV-2 Main Protease 手法: X-RAY DIFFRACTION / 解像度: 1.61 Å PDB-8tpf: Synthesis, X-Ray Crystallographic and Biological Activities of Covalent, Non-Peptidic Inhibitors of SARS-CoV-2 Main Protease 手法: X-RAY DIFFRACTION / 解像度: 1.95 Å PDB-8tpg: Synthesis, X-Ray Crystallographic and Biological Activities of Covalent, Non-Peptidic Inhibitors of SARS-CoV-2 Main Protease 手法: X-RAY DIFFRACTION / 解像度: 1.692 Å PDB-8tph: Synthesis, X-Ray Crystallographic and Biological Activities of Covalent, Non-Peptidic Inhibitors of SARS-CoV-2 Main Protease 手法: X-RAY DIFFRACTION / 解像度: 1.52 Å PDB-8tpi: Synthesis, X-Ray Crystallographic and Biological Activities of Covalent, Non-Peptidic Inhibitors of SARS-CoV-2 Main Protease 手法: X-RAY DIFFRACTION / 解像度: 1.98 Å
化合物	ChemComp-JVX: N-[(1R)-2-(tert-butylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-N-(4-tert-butylphenyl)-2-chloroacetamide ChemComp-HOH: WATER ChemComp-JJC: N-[(1R)-2-(benzylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-N-[4-(2-chloroacetamido)phenyl]furan-2-carboxamide ChemComp-JJO: N-[(1R)-2-(benzylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-N-[3-(2-chloroacetamido)phenyl]furan-2-carboxamide ChemComp-JK0: N-[(1R)-2-(benzylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-N-(4-tert-butylphenyl)-3-hydroxypropanamide ChemComp-JWI: N-(4-tert-butylphenyl)-N-[(1R)-2-(cyclohexylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-3-hydroxypropanamide ChemComp-JKL: (3R)-N-(4-tert-butylphenyl)-N-[(1R)-2-(cyclohexylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-3-hydroxybutanamide ChemComp-JWO: N-(4-tert-butylphenyl)-N-[(1R)-2-(cyclohexylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-2-hydroxy-2-methylpropanamide
由来	severe acute respiratory syndrome coronavirus 2 (ウイルス) severe acute respiratory syndrome coronavirus (SARS コロナウイルス)
キーワード	VIRAL PROTEIN/INHIBITOR / Non-Peptidic Inhibitors / Inhibitors / SARS-CoV-2 / Main Protease / Mpro / VIRAL PROTEIN / VIRAL PROTEIN-INHIBITOR complex